These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7223006)
21. The statistician's contribution to the planning and evaluation of clinical trials. Leandro G Ital J Gastroenterol; 1994; 26(1 Suppl 1):23-6. PubMed ID: 8018981 [TBL] [Abstract][Full Text] [Related]
22. Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development. Hermiston TW; Kirn DH Mol Ther; 2005 Apr; 11(4):496-507. PubMed ID: 15771953 [TBL] [Abstract][Full Text] [Related]
23. Minimizing the immunogenicity of protein therapeutics. Chirino AJ; Ary ML; Marshall SA Drug Discov Today; 2004 Jan; 9(2):82-90. PubMed ID: 15012932 [TBL] [Abstract][Full Text] [Related]
24. A show of confidence. Rothman KJ N Engl J Med; 1978 Dec; 299(24):1362-3. PubMed ID: 362205 [No Abstract] [Full Text] [Related]
25. [Multicenter clinical trials: a pressing need for the development of new therapeutics]. Boissel JP; Jaillon P; Delahaye JP; Bounhoure JP Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1393-4. PubMed ID: 3099673 [No Abstract] [Full Text] [Related]
26. [Therapy as science]. Obrecht JP; Obrist R Dtsch Med Wochenschr; 1989 Apr; 114(15):607-9. PubMed ID: 2649352 [No Abstract] [Full Text] [Related]
27. Proceedings of the Workshop on Evaluation of Therapy. September 1983. Bethesda, MD. Stat Med; 1984; 3(4):305-478. PubMed ID: 6528129 [No Abstract] [Full Text] [Related]
28. [Calculation of test power in clinical research]. Krintel JJ; Haxholdt OS Ugeskr Laeger; 1985 Apr; 147(14):1184-8. PubMed ID: 4002376 [No Abstract] [Full Text] [Related]
29. Proceedings of the Symposium on Designs for Clinical Cancer Research. Discussion II: Critical definitions and criteria for evaluation. Cancer Treat Rep; 1980; 64(2-3):469-71. PubMed ID: 7407786 [No Abstract] [Full Text] [Related]
30. Conditional power calculations for clinical trials with historical controls. Korn EL; Freidlin B Stat Med; 2006 Sep; 25(17):2922-31. PubMed ID: 16479548 [TBL] [Abstract][Full Text] [Related]
31. Designing trials and deciding on therapy in complex diseases: what can we do to improve? Knaus WA Med Decis Making; 2005; 25(4):366-9. PubMed ID: 16061887 [No Abstract] [Full Text] [Related]
32. Voices of women. Maklehemena M Integration; 1998; (57):8-9. PubMed ID: 12294631 [TBL] [Abstract][Full Text] [Related]
33. Nanoparticle therapeutics: an emerging treatment modality for cancer. Davis ME; Chen ZG; Shin DM Nat Rev Drug Discov; 2008 Sep; 7(9):771-82. PubMed ID: 18758474 [TBL] [Abstract][Full Text] [Related]
34. [Future-oriented clinical research in Germany. Biostatistics]. Forst HT Dtsch Med Wochenschr; 1999 Oct; 124(39):A15-20. PubMed ID: 10576969 [No Abstract] [Full Text] [Related]
35. Type II error in clinical trials. Gordon RS Gastroenterology; 1980 Jul; 79(1):180. PubMed ID: 7380213 [No Abstract] [Full Text] [Related]
37. Statistical methods in clinical trials. Gebski VJ; Keech AC Med J Aust; 2003 Feb; 178(4):182-4. PubMed ID: 12580749 [No Abstract] [Full Text] [Related]
38. [Clinical medicine, clinical research, and clinical epidemiology]. Raspe H Med Klin (Munich); 2004 Feb; 99(2):97-103. PubMed ID: 14963662 [No Abstract] [Full Text] [Related]
39. [n or more in clinical trials? Zelen's models for randomization]. Taube A Lakartidningen; 1994 Mar; 91(10):977-82. PubMed ID: 8139323 [No Abstract] [Full Text] [Related]
40. Benchmarking the clinical prosthetic dental literature on MEDLINE. Nishimura K; Rasool F; Ferguson MB; Sobel M; Niederman R J Prosthet Dent; 2002 Nov; 88(5):533-41. PubMed ID: 12474005 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]